IBDEI10Y ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,16658,2)
;;=^5159102
;;^UTILITY(U,$J,358.3,16659,0)
;;=D59.12^^61^775^29
;;^UTILITY(U,$J,358.3,16659,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16659,1,3,0)
;;=3^Autoimmune Hemolytic Anemia,Cold
;;^UTILITY(U,$J,358.3,16659,1,4,0)
;;=4^D59.12
;;^UTILITY(U,$J,358.3,16659,2)
;;=^5159103
;;^UTILITY(U,$J,358.3,16660,0)
;;=D59.13^^61^775^30
;;^UTILITY(U,$J,358.3,16660,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16660,1,3,0)
;;=3^Autoimmune Hemolytic Anemia,Mixed Type
;;^UTILITY(U,$J,358.3,16660,1,4,0)
;;=4^D59.13
;;^UTILITY(U,$J,358.3,16660,2)
;;=^5159104
;;^UTILITY(U,$J,358.3,16661,0)
;;=D59.19^^61^775^31
;;^UTILITY(U,$J,358.3,16661,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16661,1,3,0)
;;=3^Autoimmune Hemolytic Anemia,Other
;;^UTILITY(U,$J,358.3,16661,1,4,0)
;;=4^D59.19
;;^UTILITY(U,$J,358.3,16661,2)
;;=^5159105
;;^UTILITY(U,$J,358.3,16662,0)
;;=D57.20^^61^775^201
;;^UTILITY(U,$J,358.3,16662,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16662,1,3,0)
;;=3^Sickle-Cell/Hb-C Disease w/o Crisis
;;^UTILITY(U,$J,358.3,16662,1,4,0)
;;=4^D57.20
;;^UTILITY(U,$J,358.3,16662,2)
;;=^330080
;;^UTILITY(U,$J,358.3,16663,0)
;;=D57.211^^61^775^196
;;^UTILITY(U,$J,358.3,16663,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16663,1,3,0)
;;=3^Sickle-Cell/Hb-C Disease w/ Acute Chest Syndrome
;;^UTILITY(U,$J,358.3,16663,1,4,0)
;;=4^D57.211
;;^UTILITY(U,$J,358.3,16663,2)
;;=^5002310
;;^UTILITY(U,$J,358.3,16664,0)
;;=D57.212^^61^775^200
;;^UTILITY(U,$J,358.3,16664,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16664,1,3,0)
;;=3^Sickle-Cell/Hb-C Disease w/ Splenic Sequestration
;;^UTILITY(U,$J,358.3,16664,1,4,0)
;;=4^D57.212
;;^UTILITY(U,$J,358.3,16664,2)
;;=^5002311
;;^UTILITY(U,$J,358.3,16665,0)
;;=D57.213^^61^775^197
;;^UTILITY(U,$J,358.3,16665,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16665,1,3,0)
;;=3^Sickle-Cell/Hb-C Disease w/ Cerebral Vascular Involvement
;;^UTILITY(U,$J,358.3,16665,1,4,0)
;;=4^D57.213
;;^UTILITY(U,$J,358.3,16665,2)
;;=^5159080
;;^UTILITY(U,$J,358.3,16666,0)
;;=D57.218^^61^775^198
;;^UTILITY(U,$J,358.3,16666,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16666,1,3,0)
;;=3^Sickle-Cell/Hb-C Disease w/ Crisis w/ Oth Complication
;;^UTILITY(U,$J,358.3,16666,1,4,0)
;;=4^D57.218
;;^UTILITY(U,$J,358.3,16666,2)
;;=^5159081
;;^UTILITY(U,$J,358.3,16667,0)
;;=D57.219^^61^775^199
;;^UTILITY(U,$J,358.3,16667,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16667,1,3,0)
;;=3^Sickle-Cell/Hb-C Disease w/ Crisis,Unspec
;;^UTILITY(U,$J,358.3,16667,1,4,0)
;;=4^D57.219
;;^UTILITY(U,$J,358.3,16667,2)
;;=^5002312
;;^UTILITY(U,$J,358.3,16668,0)
;;=D57.3^^61^775^195
;;^UTILITY(U,$J,358.3,16668,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16668,1,3,0)
;;=3^Sickle-Cell Trait
;;^UTILITY(U,$J,358.3,16668,1,4,0)
;;=4^D57.3
;;^UTILITY(U,$J,358.3,16668,2)
;;=^5002313
;;^UTILITY(U,$J,358.3,16669,0)
;;=D57.40^^61^775^192
;;^UTILITY(U,$J,358.3,16669,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16669,1,3,0)
;;=3^Sickle-Cell Thalassemia w/o Crisis
;;^UTILITY(U,$J,358.3,16669,1,4,0)
;;=4^D57.40
;;^UTILITY(U,$J,358.3,16669,2)
;;=^329908
;;^UTILITY(U,$J,358.3,16670,0)
;;=D57.411^^61^775^193
;;^UTILITY(U,$J,358.3,16670,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16670,1,3,0)
;;=3^Sickle-Cell Thalassemia,Unspec w/ Acute Chest Syndrome
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI10Y 3749 printed Apr 09, 2024@21:30:17 Page 2
IBDEI10Y ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,16658,2)
+2 ;;=^5159102
+3 ;;^UTILITY(U,$J,358.3,16659,0)
+4 ;;=D59.12^^61^775^29
+5 ;;^UTILITY(U,$J,358.3,16659,1,0)
+6 ;;=^358.31IA^4^2
+7 ;;^UTILITY(U,$J,358.3,16659,1,3,0)
+8 ;;=3^Autoimmune Hemolytic Anemia,Cold
+9 ;;^UTILITY(U,$J,358.3,16659,1,4,0)
+10 ;;=4^D59.12
+11 ;;^UTILITY(U,$J,358.3,16659,2)
+12 ;;=^5159103
+13 ;;^UTILITY(U,$J,358.3,16660,0)
+14 ;;=D59.13^^61^775^30
+15 ;;^UTILITY(U,$J,358.3,16660,1,0)
+16 ;;=^358.31IA^4^2
+17 ;;^UTILITY(U,$J,358.3,16660,1,3,0)
+18 ;;=3^Autoimmune Hemolytic Anemia,Mixed Type
+19 ;;^UTILITY(U,$J,358.3,16660,1,4,0)
+20 ;;=4^D59.13
+21 ;;^UTILITY(U,$J,358.3,16660,2)
+22 ;;=^5159104
+23 ;;^UTILITY(U,$J,358.3,16661,0)
+24 ;;=D59.19^^61^775^31
+25 ;;^UTILITY(U,$J,358.3,16661,1,0)
+26 ;;=^358.31IA^4^2
+27 ;;^UTILITY(U,$J,358.3,16661,1,3,0)
+28 ;;=3^Autoimmune Hemolytic Anemia,Other
+29 ;;^UTILITY(U,$J,358.3,16661,1,4,0)
+30 ;;=4^D59.19
+31 ;;^UTILITY(U,$J,358.3,16661,2)
+32 ;;=^5159105
+33 ;;^UTILITY(U,$J,358.3,16662,0)
+34 ;;=D57.20^^61^775^201
+35 ;;^UTILITY(U,$J,358.3,16662,1,0)
+36 ;;=^358.31IA^4^2
+37 ;;^UTILITY(U,$J,358.3,16662,1,3,0)
+38 ;;=3^Sickle-Cell/Hb-C Disease w/o Crisis
+39 ;;^UTILITY(U,$J,358.3,16662,1,4,0)
+40 ;;=4^D57.20
+41 ;;^UTILITY(U,$J,358.3,16662,2)
+42 ;;=^330080
+43 ;;^UTILITY(U,$J,358.3,16663,0)
+44 ;;=D57.211^^61^775^196
+45 ;;^UTILITY(U,$J,358.3,16663,1,0)
+46 ;;=^358.31IA^4^2
+47 ;;^UTILITY(U,$J,358.3,16663,1,3,0)
+48 ;;=3^Sickle-Cell/Hb-C Disease w/ Acute Chest Syndrome
+49 ;;^UTILITY(U,$J,358.3,16663,1,4,0)
+50 ;;=4^D57.211
+51 ;;^UTILITY(U,$J,358.3,16663,2)
+52 ;;=^5002310
+53 ;;^UTILITY(U,$J,358.3,16664,0)
+54 ;;=D57.212^^61^775^200
+55 ;;^UTILITY(U,$J,358.3,16664,1,0)
+56 ;;=^358.31IA^4^2
+57 ;;^UTILITY(U,$J,358.3,16664,1,3,0)
+58 ;;=3^Sickle-Cell/Hb-C Disease w/ Splenic Sequestration
+59 ;;^UTILITY(U,$J,358.3,16664,1,4,0)
+60 ;;=4^D57.212
+61 ;;^UTILITY(U,$J,358.3,16664,2)
+62 ;;=^5002311
+63 ;;^UTILITY(U,$J,358.3,16665,0)
+64 ;;=D57.213^^61^775^197
+65 ;;^UTILITY(U,$J,358.3,16665,1,0)
+66 ;;=^358.31IA^4^2
+67 ;;^UTILITY(U,$J,358.3,16665,1,3,0)
+68 ;;=3^Sickle-Cell/Hb-C Disease w/ Cerebral Vascular Involvement
+69 ;;^UTILITY(U,$J,358.3,16665,1,4,0)
+70 ;;=4^D57.213
+71 ;;^UTILITY(U,$J,358.3,16665,2)
+72 ;;=^5159080
+73 ;;^UTILITY(U,$J,358.3,16666,0)
+74 ;;=D57.218^^61^775^198
+75 ;;^UTILITY(U,$J,358.3,16666,1,0)
+76 ;;=^358.31IA^4^2
+77 ;;^UTILITY(U,$J,358.3,16666,1,3,0)
+78 ;;=3^Sickle-Cell/Hb-C Disease w/ Crisis w/ Oth Complication
+79 ;;^UTILITY(U,$J,358.3,16666,1,4,0)
+80 ;;=4^D57.218
+81 ;;^UTILITY(U,$J,358.3,16666,2)
+82 ;;=^5159081
+83 ;;^UTILITY(U,$J,358.3,16667,0)
+84 ;;=D57.219^^61^775^199
+85 ;;^UTILITY(U,$J,358.3,16667,1,0)
+86 ;;=^358.31IA^4^2
+87 ;;^UTILITY(U,$J,358.3,16667,1,3,0)
+88 ;;=3^Sickle-Cell/Hb-C Disease w/ Crisis,Unspec
+89 ;;^UTILITY(U,$J,358.3,16667,1,4,0)
+90 ;;=4^D57.219
+91 ;;^UTILITY(U,$J,358.3,16667,2)
+92 ;;=^5002312
+93 ;;^UTILITY(U,$J,358.3,16668,0)
+94 ;;=D57.3^^61^775^195
+95 ;;^UTILITY(U,$J,358.3,16668,1,0)
+96 ;;=^358.31IA^4^2
+97 ;;^UTILITY(U,$J,358.3,16668,1,3,0)
+98 ;;=3^Sickle-Cell Trait
+99 ;;^UTILITY(U,$J,358.3,16668,1,4,0)
+100 ;;=4^D57.3
+101 ;;^UTILITY(U,$J,358.3,16668,2)
+102 ;;=^5002313
+103 ;;^UTILITY(U,$J,358.3,16669,0)
+104 ;;=D57.40^^61^775^192
+105 ;;^UTILITY(U,$J,358.3,16669,1,0)
+106 ;;=^358.31IA^4^2
+107 ;;^UTILITY(U,$J,358.3,16669,1,3,0)
+108 ;;=3^Sickle-Cell Thalassemia w/o Crisis
+109 ;;^UTILITY(U,$J,358.3,16669,1,4,0)
+110 ;;=4^D57.40
+111 ;;^UTILITY(U,$J,358.3,16669,2)
+112 ;;=^329908
+113 ;;^UTILITY(U,$J,358.3,16670,0)
+114 ;;=D57.411^^61^775^193
+115 ;;^UTILITY(U,$J,358.3,16670,1,0)
+116 ;;=^358.31IA^4^2
+117 ;;^UTILITY(U,$J,358.3,16670,1,3,0)
+118 ;;=3^Sickle-Cell Thalassemia,Unspec w/ Acute Chest Syndrome
